Baltimore-Washington Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.49M Buy
2,906
+367
+14% +$375K 0.13% 76
2026
Q1
$2.34M Sell
2,539
-839
-25% -$851K 0.1% 74
2025
Q4
$3.63M Buy
3,378
+7
+0.2% +$6.69K 0.15% 77
2025
Q3
$2.57M Buy
3,371
+2,473
+275% +$1.84M 0.11% 82
2025
Q2
$700K Buy
898
+49
+6% +$38.1K 0.03% 102
2025
Q1
$701K Buy
849
+17
+2% +$14.1K 0.04% 95
2024
Q4
$642K Buy
832
+3
+0.4% +$2.48K 0.03% 97
2024
Q3
$734K Buy
829
+7
+0.9% +$6.29K 0.04% 96
2024
Q2
$744K Buy
+822
New +$658K 0.04% 96
2024
Q1
– Sell
-785
Closed -$458K – 140
2023
Q4
$458K Sell
785
-95
-11% -$55.5K 0.03% 109
2023
Q3
$473K Buy
+880
New +$453K 0.04% 109
2015
Q4
– Sell
-200
Closed -$16K – 185
2015
Q3
$16K Hold
200
– – 0.01% 174
2015
Q2
$16K Hold
200
– – ﹤0.01% 169
2015
Q1
$15K Hold
200
– – ﹤0.01% 193
2014
Q4
$14K Buy
+200
New +$13.5K ﹤0.01% 192

Other funds holding LLY

Baltimore-Washington Financial Advisors's LLY Position: Q2 2026 in Review

Baltimore-Washington Financial Advisors increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $375K and bringing the position to 2,906 shares worth $3.49M. The position accounts for 0.13% of the portfolio, ranked #76.

Baltimore-Washington Financial Advisors first reported a position in LLY in Q4 2014 and has held it in 15 quarters since. The position peaked at $3.63M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Baltimore-Washington Financial Advisors held 2,906 shares of Eli Lilly worth $3.49M as of Q2 2026.
  • Baltimore-Washington Financial Advisors bought 367 Eli Lilly shares in Q2 2026, an estimated $375K.
  • Eli Lilly made up 0.13% of Baltimore-Washington Financial Advisors's portfolio in Q2 2026, its #76 holding.
  • Baltimore-Washington Financial Advisors first reported a position in Eli Lilly in Q4 2014 and has held it in 15 quarters since.
  • Baltimore-Washington Financial Advisors's Eli Lilly position peaked at $3.63M in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.